Page last updated: 2024-10-23

baclofen and Albinism, Oculocutaneous

baclofen has been researched along with Albinism, Oculocutaneous in 1 studies

Albinism, Oculocutaneous: Heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. The two most common are the tyrosinase-positive and tyrosinase-negative types.

Research Excerpts

ExcerptRelevanceReference
"Baclofen treatment was unsuccessful."1.30Congenital periodic alternating nystagmus. Diagnosis and Management. ( Goldstein, HP; Gradstein, L; Reinecke, RD; Wizov, SS, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gradstein, L1
Reinecke, RD1
Wizov, SS1
Goldstein, HP1

Other Studies

1 other study available for baclofen and Albinism, Oculocutaneous

ArticleYear
Congenital periodic alternating nystagmus. Diagnosis and Management.
    Ophthalmology, 1997, Volume: 104, Issue:6

    Topics: Adolescent; Adult; Aged; Albinism, Ocular; Albinism, Oculocutaneous; Baclofen; Child; Child, Prescho

1997